Spots Global Cancer Trial Database for adult malignant hemangiopericytoma

Every month we try and update this database with for adult malignant hemangiopericytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas	NCT00217620	Sarcoma	sorafenib	18 Years -	National Cancer Institute (NCI)
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma	NCT00002764	Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma	filgrastim doxorubicin hyd... ifosfamide conventional su...	16 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma	NCT00064220	Sarcoma	soblidotin	15 Years -	Daiichi Sankyo
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma	NCT00006357	Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	imatinib mesyla...	15 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma	NCT00348790	Brain and Centr... Sarcoma	vatalanib	18 Years -	Northwestern University
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma	NCT00053794	Endometrial Can... Sarcoma	perifosine	18 Years - 120 Years	Canadian Cancer Trials Group
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00003939	Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	trabectedin	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00041236	Sarcoma	exatecan mesyla...	15 Years - 75 Years	European Organisation for Research and Treatment of Cancer - EORTC
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma	NCT00041249	Gastrointestina... Sarcoma	brostallicin	15 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma	NCT00348790	Brain and Centr... Sarcoma	vatalanib	18 Years -	Northwestern University
S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas	NCT00217620	Sarcoma	sorafenib	18 Years -	National Cancer Institute (NCI)
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00003939	Brain and Centr... Endometrial Can... Gastrointestina... Ovarian Cancer Sarcoma Small Intestine...	trabectedin	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery	NCT00450736	Childhood Malig... Sarcoma	celecoxib adjuvant therap... radiation thera...	18 Years - 120 Years	University of Miami
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma	NCT00002641	Endometrial Can... Kidney Cancer Ovarian Cancer Pheochromocytom... Sarcoma	filgrastim doxorubicin hyd... ifosfamide isolated perfus... adjuvant therap... conventional su... radiation thera...	16 Years - 69 Years	European Organisation for Research and Treatment of Cancer - EORTC
Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma	NCT00423618	Sarcoma	radiotherapy	16 Years - 120 Years	Sheffield Teaching Hospitals NHS Foundation Trust
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma	NCT00740597	Sarcoma	gene expression... polymerase chai... western blottin... neoadjuvant the... therapeutic con... intensity-modul...	18 Years -	City of Hope Medical Center
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma	NCT00041236	Sarcoma	exatecan mesyla...	15 Years - 75 Years	European Organisation for Research and Treatment of Cancer - EORTC
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma	NCT00030784	Sarcoma	ifosfamide pegylated lipos...	18 Years - 70 Years	European Organisation for Research and Treatment of Cancer - EORTC
Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma	NCT01189253	Sarcoma	doxorubicin hyd... trabectedin laboratory biom... quality-of-life...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	NCT00492089	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Grade III... Adult Malignant... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineocyto... Malignant Neopl... Meningeal Melan... Radiation Toxic... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	bevacizumab placebo magnetic resona... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma	NCT00002764	Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma	filgrastim doxorubicin hyd... ifosfamide conventional su...	16 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma	NCT00041249	Gastrointestina... Sarcoma	brostallicin	15 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery	NCT00450736	Childhood Malig... Sarcoma	celecoxib adjuvant therap... radiation thera...	18 Years - 120 Years	University of Miami
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	NCT00492089	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Grade III... Adult Malignant... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineocyto... Malignant Neopl... Meningeal Melan... Radiation Toxic... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	bevacizumab placebo magnetic resona... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX	NCT00900211	Sarcoma	microarray anal... molecular diagn... biologic sample...	16 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: